Cargando…
Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997896/ https://www.ncbi.nlm.nih.gov/pubmed/27521852 http://dx.doi.org/10.1016/j.bjhh.2016.05.001 |
| _version_ | 1782449849755500544 |
|---|---|
| author | Hounkpe, Bidossessi Wilfried de Paula, Erich Vinicius |
| author_facet | Hounkpe, Bidossessi Wilfried de Paula, Erich Vinicius |
| author_sort | Hounkpe, Bidossessi Wilfried |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4997896 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49978962016-09-02 Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line Hounkpe, Bidossessi Wilfried de Paula, Erich Vinicius Rev Bras Hematol Hemoter Scientific Comment Sociedade Brasileira de Hematologia e Hemoterapia 2016 2016-05-21 /pmc/articles/PMC4997896/ /pubmed/27521852 http://dx.doi.org/10.1016/j.bjhh.2016.05.001 Text en © 2016 Associaç˜ao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Scientific Comment Hounkpe, Bidossessi Wilfried de Paula, Erich Vinicius Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line |
| title | Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line |
| title_full | Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line |
| title_fullStr | Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line |
| title_full_unstemmed | Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line |
| title_short | Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line |
| title_sort | bioengineering coagulation factors for improved hemophilia treatments(): comment on: the mutation f309s increases fviii secretion in human cell line |
| topic | Scientific Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997896/ https://www.ncbi.nlm.nih.gov/pubmed/27521852 http://dx.doi.org/10.1016/j.bjhh.2016.05.001 |
| work_keys_str_mv | AT hounkpebidossessiwilfried bioengineeringcoagulationfactorsforimprovedhemophiliatreatmentscommentonthemutationf309sincreasesfviiisecretioninhumancellline AT depaulaerichvinicius bioengineeringcoagulationfactorsforimprovedhemophiliatreatmentscommentonthemutationf309sincreasesfviiisecretioninhumancellline |